A case of bullous pemphigoid after the SARS‐CoV‐2 mRNA vaccine

A 68-year-old, otherwise healthy, man-presented-to-our-dermatology department in late April 2021 with a history-of-a-blistering-eruption-which commenced three days after his first dose of the Pfizer BioNTech COVID-19 vaccine (2nd March 2021) and worsened after the second dose given three weeks later...

Full description

Saved in:
Bibliographic Details
Published inJournal of the European Academy of Dermatology and Venereology Vol. 36; no. 1; pp. e13 - e16
Main Authors Young, J., Mercieca, L., Ceci, M., Pisani, D., Betts, A., Boffa, M.J.
Format Journal Article Web Resource
LanguageEnglish
Published England John Wiley & Sons, Inc 01.01.2022
John Wiley and Sons Inc
Subjects
COVID-19
COVID-19 Vaccines
Covid‐19 Special Forum
Humans
Letter to the Editor
mRNA Vaccines
Pemphigoid, Bullous
SARS-CoV-2
Vaccines, Synthetic
Online AccessGet full text

Cover

More Information
Summary:A 68-year-old, otherwise healthy, man-presented-to-our-dermatology department in late April 2021 with a history-of-a-blistering-eruption-which commenced three days after his first dose of the Pfizer BioNTech COVID-19 vaccine (2nd March 2021) and worsened after the second dose given three weeks later. The blisters-first-appeared-over-the sternal area and were accompanied by intense, generalised-pruritus-which-started-a-day before the blisters appeared.
ISSN:0926-9959
1468-3083
DOI:10.1111/jdv.17676